October 27, 2013
1 min read

Diabetes care improved by national self-management program

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The American Pharmacists Association Foundation released interim clinical results indicating that the first national self-management program — Project IMPACT: Diabetes — has led to reductions in HbA1c, LDL cholesterol, systolic blood pressure and BMI, according to a press release.

Interim data gathered from patients in the 25 communities in which Project IMPACT: Diabetes has been implemented show mean decreases of 0.7% in HbA1c, 7.3 mg/dL in LDL, 1.9 mm Hg in BP and 0.2 in BMI. Improvements occurred across socioeconomic class, insurance status and ethnicity, the release stated.

The program delivers customized care to patients in 25 communities with a disproportionately high incidence of diabetes. One-on-one consultations allow pharmacists to monitor patients’ HbA1c, BP, cholesterol and BMI. They can then adjust medication appropriately and provide counseling on exercise, nutrition and lifestyle changes. Pharmacists also collaborate with physicians, diabetes educators and other health care providers to ensure that patients receive comprehensive care, according to the release.

“Everyone with diabetes faces challenges such as adhering to prescribed medications, monitoring blood glucose levels, staying current with vaccines and foot and eye exams, and maintaining a healthy diet and lifestyle,” Lindsay Watson, RPh, director of applied innovation for the American Pharmacists Association Foundation, said in the release.

“Working together with pharmacists empowers all types of patients, rich and poor, insured and uninsured, anywhere in America, to take the steps they need to understand and manage their diabetes while living healthier lives.”

Disclosure: Project IMPACT: Diabetes partners with Bristol-Myers Squibb Foundation’s Together on Diabetes initiative.